Cargando…

Editorial: Health-Related Complications of Acromegaly

Detalles Bibliográficos
Autores principales:	Bolanowski, Marek, Boguszewski, Cesar L., Colao, Annamaria, Jawiarczyk-Przybyłowska, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403215/ https://www.ncbi.nlm.nih.gov/pubmed/32849286 http://dx.doi.org/10.3389/fendo.2020.00496

Ejemplares similares

Patients with Active Acromegaly are at High Risk of 25(OH)D Deficiency
por: Halupczok-Żyła, Jowita, et al.
Publicado: (2015)

Complications and Comorbidities of Acromegaly—Retrospective Study in Polish Center
por: Rolla, Małgorzata, et al.
Publicado: (2021)

Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
por: Jawiarczyk-Przybyłowska, Aleksandra, et al.
Publicado: (2020)

Association of Vitamin D Receptor Polymorphisms With Activity of Acromegaly, Vitamin D Status and Risk of Osteoporotic Fractures in Acromegaly Patients
por: Jawiarczyk-Przybyłowska, Aleksandra, et al.
Publicado: (2019)

Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly
por: Jawiarczyk-Przybyłowska, Aleksandra, et al.
Publicado: (2022)

The Effect of 6 Months’ Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings
por: Witek, Przemysław, et al.
Publicado: (2021)

Is H19 RNA a Useful Marker of Acromegaly and Its Complications? A Preliminary Study
por: Rolla, Małgorzata, et al.
Publicado: (2023)

The Relationship between the Burden of Acromegaly, Associated Comorbidities, Complications and Disease Status
por: Elbaum, Michał, et al.
Publicado: (2023)

Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly
por: Franczak, Aleksandra, et al.
Publicado: (2017)

FTO Gene Polymorphisms and Their Roles in Acromegaly
por: Jawiarczyk-Przybyłowska, Aleksandra, et al.
Publicado: (2023)

Pituitary Disorders and Osteoporosis
por: Bolanowski, Marek, et al.
Publicado: (2015)

Editorial: Insights Into Acromegaly Complications
por: Badiu, Corin, et al.
Publicado: (2022)

Pasireotide—a novel somatostatin receptor ligand after 20 years of use
por: Bolanowski, Marek, et al.
Publicado: (2022)

Health-Related Complications of Acromegaly—Risk of Malignant Neoplasms
por: Ruchala, Marek, et al.
Publicado: (2019)

Myokines in Acromegaly: An Altered Irisin Profile
por: Mizera, Łukasz, et al.
Publicado: (2021)

The Influence of SARS-CoV-2 Infection on the Thyroid Gland
por: Piekarska, Aleksandra, et al.
Publicado: (2023)

Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review
por: Zendran, Iga, et al.
Publicado: (2022)

Editorial: Personalized management of acromegaly
por: Tritos, Nicholas A.
Publicado: (2023)

Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
por: Bolanowski, Marek, et al.
Publicado: (2022)

Iron Homeostasis and Hepcidin Concentration in Patients With Acromegaly
por: Krygier, Aleksandra, et al.
Publicado: (2022)

Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs
por: Gadelha, Mônica, et al.
Publicado: (2020)

Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
por: Faggiano, Antongiulio, et al.
Publicado: (2021)

Ghrelin and Leptin Concentrations in Patients after SARS-CoV2 Infection
por: Kuliczkowska-Płaksej, Justyna, et al.
Publicado: (2023)

The Endothelium in Acromegaly
por: Maffei, Pietro, et al.
Publicado: (2019)

The acromegaly lipodystrophy
por: Freda, Pamela U.
Publicado: (2022)

Colonic Cancer and Acromegaly
por: Dworakowska, Dorota, et al.
Publicado: (2019)

Molecular targets in acromegaly
por: Labadzhyan, Artak, et al.
Publicado: (2022)

Insulin Resistance in Patients With Acromegaly
por: Vila, Greisa, et al.
Publicado: (2019)

Disposition Index in Active Acromegaly
por: Niculescu, Dan Alexandru, et al.
Publicado: (2019)

Pasireotide in the Personalized Treatment of Acromegaly
por: Puig-Domingo, Manel, et al.
Publicado: (2021)

Acromegaly and Colorectal Neoplasm: An Update
por: Kasuki, Leandro, et al.
Publicado: (2022)

Surgery for acromegaly: Indications and goals
por: Bray, David P., et al.
Publicado: (2022)

The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
por: Colao, Annamaria, et al.
Publicado: (2015)

Novel Somatostatin Receptor Ligands Therapies for Acromegaly
por: Paragliola, Rosa Maria, et al.
Publicado: (2018)

Trabecular bone score and sclerostin concentrations in patients with primary adrenal insufficiency
por: Zdrojowy-Wełna, Aleksandra, et al.
Publicado: (2022)

Can telemedicine improve adherence to medical treatment? Lessons learned from research on acromegaly conducted during COVID-19 pandemic
por: Boguszewski, Cesar Luiz
Publicado: (2022)

Frontiers in Cancer Endocrinology
por: Colao, Annamaria, et al.
Publicado: (2011)

Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life
por: Geraedts, Victor Jacobus, et al.
Publicado: (2015)

Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters
por: Geraedts, Victor J., et al.
Publicado: (2017)

The Negative Impacts of Acromegaly on Bone Microstructure Not Fully Reversible
por: Duan, Lian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_br87m2c53m3n50v4mnilpg5fiu